...
首页> 外文期刊>Journal of cell biology >Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected]
【24h】

Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected]

机译:培养的牛脑微血管内皮细胞中的糖鞘脂抗原:脱糖神经尿素糖基神经节苷脂作为脱髓鞘性神经病中单克隆IgM的靶标[已校正]

获取原文

摘要

Since a number of anti-glycosphingolipid (GSL) antibody activities have been demonstrated in patients with various neurological disorders, the presence of common antigens between brain microvascular endothelial cells (BMECs) and the nervous tissues presents a potential mechanism for the penetration of macromolecules from the circulation to the nervous system parenchyma. We first investigated GSL composition of cultured bovine BMECs. Bovine BMECs express GM3(NeuAc) and GM3(NeuGc) as the major gangliosides, and GM1, GD1a, GD1b, GT1b, as well as sialyl paragloboside and sialyl lactosaminylparagloboside as the minor species. Sulfoglucuronosyl paragloboside was also found to be a component of the BMEC acidic GSL fraction, but its concentration was lower in older cultures. On the other hand, the amounts of neutral GSLs were extremely low, consisting primarily of glucosylceramide. In addition, we analyzed the effect of anti-SGPG IgM antibody obtained from a patient of demyelinative polyneuropathy with macroglobulinemia against cultured BMECs. Permeability studies utilizing cocultured BMEC monolayers and rat astrocytes revealed that the antibody facilitated the leakage of [carboxy-14C]-inulin and 125I-labeled human IgM through BMEC monolayers. A direct cytotoxicity of this antibody against BMECs was also shown by a leakage study using [51Cr]-incorporated BMECs. This cytotoxicity depended on the concentration of the IgM antibody, and was almost completely blocked by preincubation with the pure antigen, sulfoglucuronosyl paragloboside. Our present study strongly supports the concept that immunological insults against BMECs induce the destruction or malfunction of the blood-nerve barrier, resulting in the penetration of the immunoglobulin molecule to attach peripheral nerve parenchyma.
机译:由于已在患有各种神经系统疾病的患者中证明了多种抗糖鞘脂(GSL)抗体的活性,因此脑微血管内皮细胞(BMEC)与神经组织之间存在共同抗原,为大分子从脑血管渗透提供了潜在的机制。循环至神经系统实质。我们首先研究了培养的牛BMEC的GSL组成。牛BMEC表示GM3(NeuAc)和GM3(NeuGc)是主要的神经节苷脂,而GM1,GD1a,GD1b,GT1b以及唾液酸副球蛋白和唾液酸乳糖胺基副球蛋白是次要物种。磺葡糖醛酸糖原糖苷也被发现是BMEC酸性GSL馏分的成分,但在较老的培养物中其浓度较低。另一方面,中性GSL的量极低,主要由葡糖神经酰胺组成。另外,我们分析了从患有巨球蛋白血症的脱髓鞘性多发性神经病患者获得的抗SGPG IgM抗体对培养的BMEC的作用。利用共培养的BMEC单层和大鼠星形胶质细胞的渗透性研究显示,该抗体促进了[BM-14C]-菊粉和125I标记的人IgM通过BMEC单层的泄漏。使用掺有[51Cr]的BMEC进行的渗漏研究也显示了该抗体对BMEC的直接细胞毒性。这种细胞毒性取决于IgM抗体的浓度,并通过与纯抗原磺葡糖醛糖苷副球糖苷进行预孵育而几乎完全被阻断。我们的当前研究强烈支持以下观念:针对BMEC的免疫损伤会导致血液神经屏障的破坏或功能失常,从而导致免疫球蛋白分子渗透到附着周围神经的实质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号